載入...
Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry
BACKGROUND: It is well known that patient characteristics and survival outcomes in randomized trials may not necessarily be similar to those in real-life clinical practice. The aim of the present study was to analyse second line treatment strategies in the real-world practice and to estimate the out...
Na minha lista:
| 發表在: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5740580/ https://ncbi.nlm.nih.gov/pubmed/29268716 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3901-5 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|